【机构调研记录】南华基金调研迈威生物、博隆技术

证券之星06-03

证券之星消息，根据市场公开信息及5月31日披露的机构调研信息，南华基金近期对2家上市公司进行了调研，相关名单如下：1）迈威生物（南华基金参与公司特定对象调研&路演活动&证券公司策略会）个股亮点：公司9MW2821是公司研发的一款靶向Nectin-4的ADC型创新药。2）博隆技术（南华基金参与公司特定对象调研&现场调研）个股亮点：公司主营业务为提供以气力输送为核心的粉粒体物料处理系统解决方案。；...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2440710411?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-06-03 08:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2440710411","market":"sh","top_or_hot":-1,"title":"【机构调研记录】南华基金调研迈威生物、博隆技术","media":"证券之星","content":"<div>\n<p>证券之星消息，根据市场公开信息及5月31日披露的机构调研信息，南华基金近期对2家上市公司进行了调研，相关名单如下：1）迈威生物 （南华基金参与公司特定对象调研&路演活动&证券公司策略会）个股亮点：公司9MW2821是公司研发的一款靶向Nectin-4的ADC型创新药。2）博隆技术 （南华基金参与公司特定对象调研&现场调研）个股亮点：公司主营业务为提供以气力输送为核心的粉粒体物料处理系统解决方案。；...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406030804579f1338b5&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【机构调研记录】南华基金调研迈威生物、博隆技术</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【机构调研记录】南华基金调研迈威生物、博隆技术\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-03 08:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406030804579f1338b5&s=b><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>证券之星消息，根据市场公开信息及5月31日披露的机构调研信息，南华基金近期对2家上市公司进行了调研，相关名单如下：1）迈威生物 （南华基金参与公司特定对象调研&路演活动&证券公司策略会）个股亮点：公司9MW2821是公司研发的一款靶向Nectin-4的ADC型创新药。2）博隆技术 （南华基金参与公司特定对象调研&现场调研）个股亮点：公司主营业务为提供以气力输送为核心的粉粒体物料处理系统解决方案。；...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406030804579f1338b5&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"603325","symbol_name":"博隆技术","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406030804579f1338b5&s=b","article_id":"2440710411","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406030804579f1338b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2440710411","pubTimestamp":1717372917,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"证券之星消息，根据市场公开信息及5月31日披露的机构调研信息，南华基金近期对2家上市公司进行了调研，相关名单如下：1）迈威生物 个股亮点：公司9MW2821是公司研发的一款靶向Nectin-4的ADC型创新药。2）博隆技术 个股亮点：公司主营业务为提供以气力输送为核心的粉粒体物料处理系统解决方案。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603325":"博隆技术","688062":"迈威生物","BK0259":"通用设备","BK0239":"医药制造"},"translate_title":"[Institutional Research Record] Nanhua Fund investigates Maiwei Biology and Bolong Technology","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603325":1,"688062":1},"content_text":"证券之星消息，根据市场公开信息及5月31日披露的机构调研信息，南华基金近期对2家上市公司进行了调研，相关名单如下：1）迈威生物 （南华基金参与公司特定对象调研&路演活动&证券公司策略会）个股亮点：公司9MW2821是公司研发的一款靶向Nectin-4的ADC型创新药。2）博隆技术 （南华基金参与公司特定对象调研&现场调研）个股亮点：公司主营业务为提供以气力输送为核心的粉粒体物料处理系统解决方案。；公司于2024-01-10在上交所上市南华基金成立于2016年，截至目前，资产管理规模(全部公募基金)215.48亿元，排名113/204；资产管理规模(非货币公募基金)215.48亿元，排名103/204；管理公募基金数30只，排名122/204；旗下公募基金经理6人，排名136/204。旗下最近一年表现最佳的公募基金产品为南华瑞泰39个月定开A，最新单位净值为1.02，近一年增长6.05%。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2440710411"}